Reportlinker Adds Global Coronary Stents Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

NEW YORK, June 21 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Coronary Stents Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

http://www.reportlinker.com/p0208577/Global-Coronary-Stents-Pipeline-Analysis-Opportunity-Assessment-and-Market-Forecasts-to-2016.html

Global Coronary Stents Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Summary

GlobalData's medical equipment report, "Global Coronary Stents Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016" provides key data, information and analysis on the global coronary stents market, a key segment within cardiovascular devices. The report provides market landscape, competitive landscape and market trends information the coronary stents market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Key geographies covered include the US (United States), Canada, the UK (United Kingdom), Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.

- Key segments covered include Bare Metal Stents (BMS) and Drug Eluting Stents (DES).

- Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2008.

- Qualitative analysis of key market trends, market drivers, and restraints by each category within the coronary stents market.

- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.

- Key players covered include Cordis, Boston Scientific Corporation, Medtronic and Abbott.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the coronary stents market globally.

- Design and develop your product development, marketing and sales strategies.

- Exploit M&A opportunities by identifying market players with the most innovative pipeline.

- Develop market-entry and market expansion strategies.

- Identify key players best positioned to take advantage of the emerging market opportunities.

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.

- What's the next being thing in the coronary stents market landscape? – Identify, understand and capitalize.

- Make more informed business decisions from the insightful and in-depth analysis of the global coronary stents market and the factors shaping it.

1 Table of contents 3

1.1 List of Tables 6

1.2 List of Figures 8

2 Introduction: Coronary Stents 9

2.1 GlobalData Report Guidance 9

3 Disease Overview: Coronary Heart Disease (CHD) 10

3.1 Pathophysiology 11

3.2 Signs and Symptoms 12

3.3 Risk Factor 12

3.3.1 Major Risk Factors that can't be Altered 12

3.3.2 Major Risk Factors that can be Altered 12

3.3.3 Other Risk Factors 13

3.4 Diagnosis 13

3.4.1 Electrocardiogram (ECG or EKG): 13

3.4.2 Exercise thallium test: 13

3.4.3 Echocardiography: 13

3.4.4 Coronary angiography: 13

3.4.5 Positron Emission Tomography (PET scanning): 13

3.5 Treatment 14

3.5.1 Coronary Heart Disease Epidemiology 14

3.5.2 Treatment modalities for CHD 16

4 Global Coronary Stents Market Characterization 18

4.1 Global Coronary Stents Market, Revenues ($bn), Historic, 2002 – 2009 18

4.2 Global Coronary Stents Market, Revenues ($bn), Forecast, 2009 – 2016 19

4.3 Global Coronary Stents, Market Dynamics 20

4.3.1 Coronary Stents: Market Drivers 20

4.3.2 Coronary Stents: Market Restraints 22

5 Global Coronary Stents Market: Segment Analysis 24

5.1 Bare Metal Stents, Global, Revenue ($bn), Historic, 2002– 2009 24

5.1.1 Bare Metal Stents, Global, Revenue ($bn), Forecast, 2009– 2016 25

5.2 Global Bare Metal Stents: Market Dynamics 26

5.2.1 Bare Metal Stents: Market Drivers 26

5.2.2 Bare Metal Stents: Market Restraints 26

5.2.3 Drug Eluting Stents, Global, Revenue ($bn), Historic, 2002– 2009 27

5.2.4 Drug Eluting Stents, Global, Revenue ($bn), Forecast, 2009– 2016. 28

5.3 Global Drug Eluting Stents:Market Dynamics 28

5.3.1 Drug Eluting Stents: Market Drivers 28

5.3.2 Drug Eluting Stents: Market Restraints 29

6 The Global Coronary Stents Market: Cross Country Analysis and Forecasts 30

6.1 Revenue and Revenue Forecast, By Country 31

6.1.1 US Coronary Stents market, Revenue ($ m), Historic, 2002-2009 31

6.1.2 US Coronary Stents market, Revenue ($ m), Forecast, 2009-2016 32

6.1.3 Canada Coronary Stents market, Revenue ($ m), Historic, 2002-2009 33

6.1.4 Canada, Coronary Stents market, Revenue ($ m), Forecast, 2002-2009 34

6.1.5 UK Coronary Stents market, Revenue ($ m), Historic, 2002-2009 35

6.1.6 UK Coronary Stents market, Revenue ($ m), Forecast, 2009-2016 36

6.1.7 Italy, Coronary Stents market, Revenue ($ m), Historic, 2002-2009 37

6.1.8 Germany, Coronary Stents market, Revenue ($ m), Historic, 2002-2009 39

6.1.9 Germany, Coronary Stents market, Revenue ($ m), Forecast, 2009-2016 40

6.1.10 France, Coronary Stents market, Revenue ($ m), Historic, 2002-2009 41

6.1.11 France, Coronary Stents market, Revenue ($ m), Forecast, 2009-2016 42

6.1.12 Spain, Coronary Stents market, Revenue ($ m), Historic, 2002-2009 43

6.1.13 Spain, Coronary Stents market, Revenue ($ m), Forecast, 2009-2016 44

6.1.14 Japan, Coronary Stents market, Revenue ($ m), Historic, 2002-2009 45

6.1.15 Japan, Coronary Stents market, Revenue ($ m), Forecast, 2009-2016 46

6.1.16 China, Coronary Stents market, Revenue ($ m), Historic, 2002-2009 47

6.1.17 China, Coronary Stents market, Revenue ($ m), Forecast, 2009-2016 48

6.1.18 India, Coronary Stents market, Revenue ($ m), Historic, 2002-2009 49

6.1.19 India, Coronary Stents market, Revenue ($ m), Forecast, 2009-2016 50

6.1.20 Brazil, Coronary Stents market, Revenue ($ m), Historic, 2002-2009 51

6.1.21 Brazil, Coronary Stents market, Revenue ($ m), Forecast, 2009-2016 52

6.1.22 Australia, Coronary Stents market, Revenue ($ m), Historic, 2002-2009 53

6.1.23 Australia, Coronary Stents market, Revenue ($ m), Forecast, 2009-2016 54

7 Global Coronary Stents Market: Strategic Competitive Assessment 55

7.1 Boston Scientific Corporation 57

7.1.1 Overview: 57

7.2 Cordis Corporation 58

7.2.1 Overview 58

7.3 Abbott Laboratories 59

7.3.1 Overview 59

7.4 Medtronic, Inc. 60

7.4.1 Overview 60

8 Global coronary Stents Market, Key Marketed products 62

8.1 Key Coronary Stents in the Market 62

8.1.1 CYPHER sirolimus-eluting coronary stents (JNJ Cordis) 62

8.1.2 PROMUS (Boston Scientific) 65

8.1.3 ENDEAVOR (Medtronic) 68

8.1.4 TAXUS Express2 (Boston Scientific) 71

8.1.5 TAXUS Liberte (Boston Scientific) 73

8.1.6 TriMaxx Coronary Stent (Abbott) 75

8.1.7 MULTI-LINK FRONTIER Coronary Bifurcation Stent System (Abbott) 75

9 Global Coronary Stents Market: Strategic Pipeline Assessment 76

9.1 Pipeline Technology Assessment 76

9.1.1 Pipeline Technology Assessment for Coronary Stents by Development Stage, Global 76

9.1.2 Emerging Technologies in the Coronary Stent Market 79

9.2 Profiles of Promising Products Under Clinical Development: 80

9.2.1 BioMatrix Drug Eluting Stent (Biosensors) 80

9.2.2 NEVO Sirolimus-eluting Coronary Stent (Cordis) 82

9.2.3 PROTEX Coronary Stent System (Nexeon MedSystems) 85

9.2.4 Valecor Platinum Coronary Stent System (CorNova) 85

9.2.5 GTX Coronary Stent System (Cook Medical) 86

9.2.6 JST Drug-Eluting Stent (Japan Stent Technology) 87

9.2.7 ProGenic Pimecrolimus-eluting Coronary Stent System (BIOTRONIK SE & Co. KG) 87

9.2.8 MAHOROBA (KANEKA CORPORATION) 88

9.2.9 ProLink LP (Vascular Concepts Limited) 89

9.2.10 ChromoFlex Coronary Stent (DISA Vascular) 90

9.2.11 Next generation everolimus-based stent (Boston Scientific) 91

9.2.12 ProNova Sirolimus Eluting Stent (Vascular Concepts Limited) 91

9.2.13 Coroflex DEBlue (B. Braun Melsungen AG) 92

9.2.14 Endeavor Resolute (Medtronic) 94

9.2.15 XIENCE NANO (Abbott Vascular) 96

9.2.16 TAXUS Petal Bifurcation Paclitaxel-Eluting Stent System (Boston Scientific) 96

9.2.17 CYPHER Max (4.0) (RX) (Cordis Corporation) 99

9.3 Coronary Stents:List of Pipeline Products 99

10 Global Coronary Stents Market: Key Companies with Products in Clinical Development 106

10.1.1 Biosensors International Group, Ltd. 106

10.1.2 Cook Medical Incorporated 106

10.1.3 OrbusNeich 107

10.1.4 Vascular Concepts Limited 108

10.1.5 CorNova, Inc. 108

10.1.6 Nexeon MedSystems, Inc. 109

11 Global Coronary Stents Market: Strategic Deals Analysis 110

11.1 Key Acquisitions 110

11.1.1 Medtronic Completes Acquisition Of Invatec And Affiliated Companies 111

11.1.2 Boston Scientific Acquires Labcoat 111

11.1.3 Bayer MaterialScience Completes Acquisition Of PolyBioMed From Lombard Medical Technologies 111

12 Appendix 113

12.1 Definitions 113

12.1.1 Coronary Stents 113

12.2 Acronyms 113

12.3 Research Methodology 114

12.4 Secondary Research 115

12.5 Primary Research 115

12.6 Models 116

12.7 Forecasts 116

12.8 Expert Panels 116

12.9 GlobalData Consulting 117

12.10 Contact Us 117

12.11 Disclaimer 117

1.1 List of Tables

Table 1: Coronary Stents Market, Global, Revenue ($bn), 2002 – 2009 18

Table 2: Coronary Stents Market, Global, Revenue ($bn), 2009 – 2016 19

Table 3: Bare Metal Stents, Global, Revenue ($bn), 2002– 2009 24

Table 4: Bare Metal Stents, Global, Revenue ($bn), 2009–2016 25

Table 5: Drug Eluting Stents Market, Global, Revenue ($bn), 2002– 2009 27

Table 6: Drug Eluting Stents, Global, Revenue ($bn), 2009– 2016 28

Table 7: Coronary Stents Market, Cross Country Analysis, Revenue ($m) and CAGR (%), 2002-2016 30

Table 8: Coronary Stents Market, US, Revenue ($ m), 2002-2009 31

Table 9: Coronary Stents Market, US, Revenue ($ m), 2009-2016 32

Table 10:Coronary Stents Market, Canada, Revenue ($ m), 2002-2009 33

Table 11:Coronary Stents Market, Canada, Revenue ($ m), 2009-2016 34

Table 12: Coronary Stents Market, UK, Revenue ($ m), 2002-2009 35

Table 13: Coronary Stents Market, UK, Revenue ($ m), 2009-2016 36

Table 14: Coronary Stents Market, Italy, Revenue ($ m), 2002-2009 37

Table 15: Coronary Stents Market, Italy, Revenue ($ m), 2009-2016 38

Table 16: Coronary Stents Market, Germany, Revenue ($ m), 2002-2009 39

Table 17: Coronary Stents Market, Germany, Revenue ($ m), 2009-2016 40

Table 18: Coronary Stents Market, France, Revenue ($ m), 2002-2009 41

Table 19: Coronary Stents Market, France, Revenue ($ m), 2009-2016 42

Table 20: Coronary Stents Market, Spain, Revenue ($ m), 2002-2009 43

Table 21: Coronary Stents Market, Spain, Revenue ($ m), 2009-2016 44

Table 22: Coronary Stents Market, Japan, Revenue ($ m), 2002-2009 45

Table 23: Coronary Stents Market, Japan, Revenue ($ m), 2009-2016 46

Table 24: Coronary Stents Market,China, Revenue ($ m), 2002-2009 47

Table 25: Coronary Stents Market,China, Revenue ($ m), 2009-2016 48

Table 26: Coronary Stents Market, India, Revenue ($ m), 2002-2009 49

Table 27: Coronary Stents Market, India, Revenue ($ m), 2009-2016 50

Table 28: Coronary Stents Market, Brazil, Revenue ($ m), 2002-2009 51

Table 29: Coronary Stents Market, Brazil, Revenue ($ m), 2009-2016 52

Table 30: Coronary Stents Market, Australia, Revenue ($ m), 2002-2009 53

Table 31: Coronary Stents Market, Australia, Revenue ($ m), 2009-2016 54

Table 32: Drug Eluting Stents Market , Global, Company Shares Revenue ($m), 2009 55

Table 33: Bare Metal Stents Market, Global, Company Shares Revenue ($m), 2009 56

Table 34: Boston Scientific Corporation, Coronary Stents, Pipeline Products 58

Table 35: Cordis, Coronary Stents, Pipeline Products 59

Table 36: Abbott Coronary Stents Pipeline Products 60

Table 37: Medtronic Coronary Stents Pipeline Products 61

Table 38: Current Drug-Eluting Stents Approved for Use in the US 62

Table 39: CYPHER Coronary Stent 62

Table 40: CYPHER (SIRIUS Pivotal Trial) 63

Table 41: CYPHER (RAVEL Supporting Trial) 64

Table 42: PROMUS Coronary Stent 65

Table 43: PROMUS (SPIRIT III Trial)) 66

Table 44: ENDEAVOR Coronary Stent 68

Table 45: ENDEAVOR (ENDEAVOR III Trial)) 68

Table 46: ENDEAVOR (ENDEAVOR IV Trial)) 70

Table 47: TAXUS Express2 (TAXUS IV Trial)) 72

Table 48: TAXUS Liberte (ATLAS Trial)) 74

Table 49: Biomatrix III (LEADER Trial) 80

Table 50: Biomatrix (STEALTH) 82

Table 51: NEVO Sirolimus-eluting coronary stent (RES-ELUTION II) 83

Table 52: NEVO Sirolimus-eluting coronary stent (RES-ELUTION I): Pivotal trial 85

Table 53: GTX Coronary Stent System 86

Table 54: ProGenic Pimecrolimus-eluting Coronary Stent System 87

Table 55: MAHOROBA 89

Table 56: ProLink LP 90

Table 57: ChromoFlex Coronary Stent 91

Table 58: ProNova Sirolimus Eluting Stent 92

Table 59: Coroflex DEBlue (PEPCADIIIsub) 93

Table 60: ENDEAVOR Resolute 94

Table 61: TAXUS Petal Bifurcation Paclitaxel-Eluting Stent System 97

Table 62: Coronary Stents : Pipeline Summary 99

Table 63: Coronary Stents Pipeline Products 106

Table 64: Coronary Stents Pipeline Products 107

Table 65: Coronary Stents Pipeline Products 107

Table 66: Coronary Stents Pipeline Products 108

Table 67: Coronary Stents Pipeline 109

Table 68: Coronary Stents Pipeline Products 109

Table 69: Coronary Stents: Key Acquisitions 110

1.2 List of Figures

Figure 1: Build up of Plaque in the Arteries 10

Figure 2: Atherosclerosis with Blood Clot and Arteries with Spasm 11

Figure 3: Signs and Symptoms of Coronary Heart Disease 12

Figure 4: Treatment Flow Model, Coronary Stents for Treatment of Coronary Heart Disease, US, 2009 14

Figure 5: Treatment Flow Model, Coronary Stents for Treatment of Coronary Heart Disease, Europe, 2009 14

Figure 6: Treatment Modalities for Coronary Heart Disease, 2009 16

Figure 7: Stent Procedure with Baloon Angioplasty 17

Figure 8: Coronary Stents Market, Global, Revenue ($bn), 2002 – 2009 18

Figure 9: Coronary Stents Market, Global, Revenue ($bn), 2009 – 2016 19

Figure 10: Drivers and Restraints in the Coronary Stents Market 20

Figure 11: US, Breakdown of Deaths from Cardiovascular Diseases, %,2006 20

Figure 12 Bare Metal Stents Market, Global, Revenue ($bn), 2002– 2009 24

Figure 13: Bare Metal Stents Market, Global, Revenue ($bn), 2009–2016 25

Figure 14: Drug Eluting Stents Market, Global, Revenue ($bn), 2002–2009 27

Figure 15: Drug Eluting Stents Market, Global, Revenue ($bn), 2009– 2016 28

Figure 16: Coronary Stents Market, Cross Country Analysis, Global, Revenue and growth Comparison 2002-2016 30

Figure 17: Coronary Stents Market, US, Revenue ($ m), 2002-2009 31

Figure 18: Coronary Stents Market, US, Revenue ($ m), 2009-2016 32

Figure 19: Coronary Stents Market, Canada, Revenue ($ m), 2002-2009 33

Figure 20: Coronary Stents Market, Canada, Revenue ($ m), 2009-2016 34

Figure 21: Coronary Stents Market, UK, Revenue ($ m), 2002-2009 35

Figure 22: Coronary Stents Market, UK, Revenue ($ m), 2009-2016 36

Figure 23: Coronary Stents Market, Italy, Revenue ($ m), 2002-2009 37

Figure 24: Coronary Stents Market, Italy, Revenue ($ m), 2009-2016 38

Figure 25: Coronary Stents Market, Germany, Revenue ($ m), 2002-2009 39

Figure 26: Coronary Stents Market, Germany, Revenue ($ m), 2009-2016 40

Figure 27: Coronary Stents Market, France, Revenue ($ m), 2002-2009 41

Figure 28: Coronary Stents Market, France, Revenue ($ m), 2009-2016 42

Figure 29: Coronary Stents Market, Spain, Revenue ($ m), 2002-2009 43

Figure 30: Coronary Stents Market, Spain, Revenue ($ m), 2009-2016 44

Figure 31: Coronary Stents Market, Japan, Revenue ($ m), 2002-2009 45

Figure 32: Coronary Stents Market, Japan, Revenue ($ m), 2009-2016 46

Figure 33: Coronary Stents Market,China, Revenue ($ m), 2002-2009 47

Figure 34: Coronary Stents Market, China, Revenue ($ m), 2009-2016 48

Figure 35: Coronary Stents Market, India, Revenue ($ m), 2002-2009 49

Figure 36: Coronary Stents Market, India, Revenue ($ m), 2009-2016 50

Figure 37: Coronary Stents Market, Brazil, Revenue ($ m), 2002-2009 51

Figure 38: Coronary Stents Market, Brazil, Revenue ($ m), 2009-2016 52

Figure 39: Coronary Stents Market, Australia, Revenue ($ m), 2002-2009 53

Figure 40: Coronary Stents Market, Australia, Revenue ($ m), 2009-2016 54

Figure 41: Drug Eluting Stents Market, Global, Company Share (% of Revenue), 2009 55

Figure 42: Bare Metal Stents Market, Global, Company Shares (% Revenue), 2009 56

Figure 43: Pipeline Technology Assessment for Coronary Stents by Development Stage, Global 76

Figure 44: Pipeline Technology Assessment for Drug Eluting and Bare Metal Stents By Development Stage, Global 77

Figure 45: Pipeline Technology Assessment for Drug Eluting Stents by Unmet Need, Global 78

Figure 46: Pipeline Technology Assessment for Bare Metal Stents by Unmet Need, Global 79

Figure 47: Key Acquisitions in 2009-2010 110

Figure 48: GlobalData Methodology 115

Companies mentioned

Biosensors International Group, Ltd.

Cook Medical Incorporated

OrbusNeich

Vascular Concepts Limited

CorNova, Inc.

Nexeon MedSystems, Inc.

To order this report:

Medical Devices Industry: Global Coronary Stents Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Contact

Nicolas Bombourg

Reportlinker

Email: [email protected]

US: (805)652-2626

Intl: +1 805-652-2626

SOURCE Reportlinker